IMGT (XKRX:456570) Capex-to-Operating-Income : 0.00 (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is IMGT Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

IMGT's Capital Expenditure for the six months ended in Dec. 2023 was ₩-478.38 Mil. Its Operating Income for the six months ended in Dec. 2023 was ₩-6,683.25 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.

IMGT Capex-to-Operating-Income Historical Data

The historical data trend for IMGT's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMGT Capex-to-Operating-Income Chart

IMGT Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Capex-to-Operating-Income

IMGT Semi-Annual Data
	Dec20	Dec21	Dec22	Dec23
Capex-to-Operating-Income	-	-	-	-

Competitive Comparison of IMGT's Capex-to-Operating-Income

For the Biotechnology subindustry, IMGT's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IMGT's Capex-to-Operating-Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IMGT's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where IMGT's Capex-to-Operating-Income falls into.

IMGT Capex-to-Operating-Income Calculation

IMGT's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (-478.379)	/	-6683.251
	=	N/A

IMGT's Capex-to-Operating-Income for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (-478.379)	/	-6683.251
	=	N/A

IMGT (XKRX:456570) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.

IMGT Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of IMGT's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.

IMGT (XKRX:456570) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IMGT Corp Ltd (XKRX:456570) » Definitions » Capex-to-Operating-Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

172 Dolma-ro,, 408, Healthcare Innovation Park, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13605

Website

http://www.imgt.co.kr

IMGT Corp Ltd develops a focused ultrasound-based drug delivery platform for intractable diseases. It is developing nanomedicines and focused ultrasound medical devices that respond to focused ultrasound. The firm has two pipeline products IMD20 and IMP101. IMD20 is a FUS device developed for chronic pain as a product with reduced size and output from IMD10 developed for cancer treatment. IMP101 is a nanoparticle used for hepatocarcinoma embolization.

IMGT (XKRX:456570) Headlines

No Headlines